Document is current
Any future updates will be listed below
-
Authors
Olson, Robert http://orcid.org/0000-0003-4532-6197
Mathews, Lindsay
Liu, Mitchell
Schellenberg, Devin
Mou, Benjamin
Berrang, Tanya
Harrow, Stephen
Correa, Rohann J. M.
Bhat, Vasudeva
Pai, Howard
Mohamed, Islam
Miller, Stacy
Schneiders, Famke
Laba, Joanna
Wilke, Derek
Senthi, Sashendra
Louie, Alexander V.
Swaminath, Anand
Chalmers, Anthony
Gaede, Stewart
Warner, Andrew
de Gruijl, Tanja D.
Allan, Alison
Palma, David A.
-
Funding
Funding for this research was provided by:
Canadian Institute for Health Research (427096)
Varian Medical Systems
BC Cancer Agency
- License Information
-
More Information
Article History
Received: 16 March 2020
Accepted: 16 April 2020
First Online: 5 May 2020
Ethics approval and consent to participate
: Ethics approval has been obtained from the joint University of British Columbia and BC Cancer Research Ethics Board (H18–03173). As the study opens in other jurisdictions, ethics approval will be obtained in each jurisdiction. Written consent to participate will be obtained from individual study participants and will include consent to undergo study interventions as well as biomarker assessment. Consent will be obtained at individual participating institutions by study investigators or clinical trials staff members.
: Not applicable.
: None to declare from the study sponsor, Principle Investigators, any study investigators, or any translation scientists.
